3 (CRHC) Certified Rheumatology Coder jobs

The Certified Rheumatology Coder (CRHC™) exam was developed by a team of leading rheumatology coding professionals in conjunction with the American College of Rheumatology (ACR). Experienced rheumatology coders are encouraged to sit for the CHRC exam. CRHC certification validates coding proficiency in the medical field of rheumatology, including surgical procedures like trigger point injections, joint injections, synovial fluid analysis, viscosupplementation, etc.

The CHRC certification exam will test:

  • Ability to read and abstract physician office notes and operative notes to apply correct ICD-10-CM, CPT®, HCPCS Level II, and modifier coding assignments
  • Application of CPT® evaluation and management (E/M) guidelines
  • Rules and regulations for Medicare billing — including incident to, teaching situations, shared visits, consultations, and global surgery
  • Coding of surgical procedures commonly performed by rheumatologists such as aspirations, nailfold videocapillaroscopies, ultrasound-guided cortisone injections, etc.
  • Medical terminology
  • Anatomy and physiology
 
Associate Director, Medical Science Liaison (MSL), Rheumatology
Zenas BioPharma Waltham, MA, USA
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas' lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab's unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively...

Jan 05, 2026
Associate Director, Rheumatology MSL — Field Medical Leader
Zenas BioPharma Waltham, MA, USA
A leading biopharmaceutical company seeks an Associate Director, Medical Science Liaison, specifically for Rheumatology. This role involves engaging with healthcare professionals to educate them on the company's product portfolio, supporting clinical research efforts, and maintaining vital relationships with key opinion leaders in the field. The ideal candidate will possess an advanced clinical degree and experience in a field-based or clinical position, while demonstrating strong communication and interpersonal skills. Compensation ranges between $181,600 to $227,000. #J-18808-Ljbffr

Dec 25, 2025
Associate Director, Medical Science Liaison (MSL), Rheumatology
Zenas BioPharma Waltham, MA, USA
Associate Director, Medical Science Liaison (MSL), Rheumatology – Zenas BioPharma Territory: Northwest (AK, NE, SD, ND, MT, WY, CO, UT, ID, WA, OR) Zenas is a clinical‑stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late‑stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without...

Dec 25, 2025